Mediclinic International's share price fell as much as 6% to R105 on Thursday after it reported an interim loss and indicated it may reduce its bid to buy the 70% of UK associate Spire Healthcare it does not already own. London-listed Spire Healthcare's share price fell 7% to 275p after Mediclinic said it would "take into account the movement in its share price since October 17" when considering a final bid it is required to make by 5pm on Friday under London Stock Exchange rules. "There can be no certainty that an offer will be made," Mediclinic said in a statement on Thursday. Spire said on October 23 it considered Mediclinic's offer of  0.232 Mediclinic shares and 150p per share in cash too low. Mediclinic International incurred a loss attritutable to shareholders of £50m in the six months to end-September, which it blamed on the impairment charge on the equity investment in Spire Healthcare Group and other exceptional items. Mediclinic’s underlying earnings were down 11% to £84m...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.